Beese Fulmer Investment Management Inc. Raises Position in UnitedHealth Group Incorporated (NYSE:UNH)

Beese Fulmer Investment Management Inc. raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 23,271 shares of the healthcare conglomerate’s stock after buying an additional 511 shares during the quarter. Beese Fulmer Investment Management Inc.’s holdings in UnitedHealth Group were worth $11,772,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Fairvoy Private Wealth LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth approximately $420,000. Livforsakringsbolaget Skandia Omsesidigt raised its stake in UnitedHealth Group by 441.9% during the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 40,162 shares of the healthcare conglomerate’s stock worth $20,316,000 after acquiring an additional 32,750 shares during the period. BSN CAPITAL PARTNERS Ltd raised its holdings in UnitedHealth Group by 50.1% during the fourth quarter. BSN CAPITAL PARTNERS Ltd now owns 72,818 shares of the healthcare conglomerate’s stock valued at $36,418,000 after acquiring an additional 24,298 shares during the period. Sumitomo Mitsui Trust Group Inc. raised its position in shares of UnitedHealth Group by 0.5% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,619,549 shares of the healthcare conglomerate’s stock valued at $1,325,125,000 after buying an additional 12,322 shares during the last quarter. Finally, Spectrum Asset Management Inc. NB CA lifted its position in shares of UnitedHealth Group by 5.9% in the fourth quarter. Spectrum Asset Management Inc. NB CA now owns 6,304 shares of the healthcare conglomerate’s stock worth $3,189,000 after buying an additional 352 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Morgan Stanley dropped their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Barclays cut their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. Truist Financial reduced their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Finally, Bank of America dropped their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Down 1.9 %

Shares of UnitedHealth Group stock opened at $529.71 on Friday. The stock has a market cap of $487.48 billion, a PE ratio of 34.17, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The business has a fifty day simple moving average of $532.43 and a 200 day simple moving average of $564.77. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the company earned $5.83 earnings per share. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. Research analysts predict that UnitedHealth Group Incorporated will post 29.63 EPS for the current year.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.